Transglutaminase regulation of cell function

RL Eckert, MT Kaartinen, M Nurminskaya… - Physiological …, 2014 - journals.physiology.org
Transglutaminases (TGs) are multifunctional proteins having enzymatic and scaffolding
functions that participate in regulation of cell fate in a wide range of cellular systems and are …

Tissue transglutaminase: A multifunctional and multisite regulator in health and disease

Z Yao, Y Fan, L Lin, RE Kellems… - Physiological …, 2024 - journals.physiology.org
Tissue transglutaminase (TG2) is a widely distributed multifunctional protein involved in a
broad range of cellular and metabolic functions carried out in a variety of cellular …

TagGraph reveals vast protein modification landscapes from large tandem mass spectrometry datasets

A Devabhaktuni, S Lin, L Zhang, K Swaminathan… - Nature …, 2019 - nature.com
Although mass spectrometry is well suited to identifying thousands of potential protein post-
translational modifications (PTMs), it has historically been biased towards just a few. To …

[HTML][HTML] Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma

H Hidaka, N Seki, H Yoshino, T Yamasaki, Y Yamada… - Oncotarget, 2012 - ncbi.nlm.nih.gov
MicroRNAs (miRNA) are non-coding RNAs, approximately 22 nucleotides in length, which
function as post-transcriptional regulators. A large body of evidence indicates that miRNAs …

Transglutaminase 2 inhibitors and their therapeutic role in disease states

M Siegel, C Khosla - Pharmacology & therapeutics, 2007 - Elsevier
Transglutaminase 2 (TG2) is a multi-domain, multi-functional enzyme that post-
translationally modifies proteins by catalyzing the formation of intermolecular isopeptide …

Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer

K Mehta, A Kumar, H Im Kim - Biochemical pharmacology, 2010 - Elsevier
Metastasis of primary tumors to distant sites and their inherent or acquired resistance to
currently available therapies pose major clinical challenge to the successful treatment of …

Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis

A Verma, H Wang, B Manavathi, JY Fok, AP Mann… - Cancer research, 2006 - AACR
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive neoplastic
diseases and is virtually incurable. The molecular mechanisms that contribute to the intrinsic …

[HTML][HTML] Transglutaminase 2 in human diseases

Z Szondy, I Korponay-Szabó, R Király, Z Sarang… - BioMedicine, 2017 - ncbi.nlm.nih.gov
Abstract Transglutaminase 2 (TG2) is an inducible transamidating acyltransferase that
catalyzes Ca (2+)-dependent protein modifications. In addition to being an enzyme, TG2 …

Transglutaminase is a tumor cell and cancer stem cell survival factor

RL Eckert, ML Fisher, D Grun, G Adhikary… - Molecular …, 2015 - Wiley Online Library
Recent studies indicate that cancer cells express elevated levels of type II transglutaminase
(TG2), and that expression is further highly enriched in cancer stem cells derived from these …

Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21‐mediated ubiquitination/degradation of STAT1 in a GTP binding …

L Zhang, Q Li, J Yang, P Xu, Z Xuan… - Cancer …, 2023 - Wiley Online Library
Background Previous studies have revealed the critical role of transglutaminase 2 (TGM2)
as a potential therapeutic target in cancers, but the oncogenic roles and underlying …